Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genome is Scopus-indexed (Q3, CiteScore 3), WoS SCIE. Published by Canadian Science Publishing.
Checked against the index lists dated .
ISSN 0831-2796Verify ISSN ↗1480-3321Verify ISSN ↗
Publisher: Canadian Science Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 198 / 325 | 39th | Q3 |
| Genetics | 248 / 357 | 30th | Q3 |
| Molecular Biology | 322 / 414 | 22nd | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q3, CiteScore 3.
Genome is Q3 in Biotechnology (rank 198 of 325), Q3 in Genetics (rank 248 of 357) and Q4 in Molecular Biology (rank 322 of 414), by CiteScore 2025.
Genome is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3, which places it in quartile Q3 at the 39th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.442, quartile Q3, with an H-index of 113.
Genome is published by Canadian Science Publishing. Its print ISSN is 0831-2796 and its online ISSN is 1480-3321.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Genome has an h-index of 148 and a 2-year mean of 1.84 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q3. On 2-year citations it ranks #187 of 309 Scopus journals in Biotechnology.
Genome published 57 papers in 2025; its busiest recent year was 2020 with 92. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from Canada (34.3%), Brazil (20.7%) and China (9.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.